22
Among several commercial enzymes screened for chitosanolytic activity, Neutrase 0.8L 23 (a protease from Bacillus amyloliquefaciens) was selected in order to obtain a product 24 enriched in deacetylated chitooligosaccharides (COS). The hydrolysis of different 25 chitosans with this enzyme was followed by size exclusion chromatography (SEC-26 ELSD), mass spectrometry (ESI-Q-TOF), and high-performance anion-exchange 27 chromatography with pulsed amperometric detection (HPAEC-PAD). Neutrase 0.8L 28 converted 10 g/L of various chitosans into mostly deacetylated oligosaccharides, 29 yielding approximately 2.5 g/L of chitobiose, 4.5 g/L of chitotriose and 3 g/L of 30 chitotetraose. We found out that the neutral protease was not responsible of the 31 chitosanolytic activity in the extract, whilst it could participate in the deacetylating 32 process. The synthesized COS were tested in vitro for their neuroprotective (towards 33 human SH-S5Y5 neurons) and anti-inflammatory (in RAW macrophages) activities, 34
and compared with other functional ingredients, namely fructooligosaccharides. 35
INTRODUCTION

36
Chitin, the second most abundant polymer in nature after cellulose, is formed by N-37 acetyl-glucosamine (GlcNAc) moieties linked by β(1→4) bonds. It is a cheap and 38 available feedstock that can be obtained from crustacean shells (more than 10,000 tons 39
per year) and fungi (Hamed et al. 2016 ); however, its applicability is limited by its low 40 aqueous solubility. Total or partial deacetylation of chitin, by chemical or enzymatic 41 methods, yields chitosan, a biodegradable and non-toxic biopolymer that is employed as 42 drug carrier (Varshosaz et al. 2006 ), in bone repair (Jayakumar et al. 2010, Muzzarelli 43 2009), gene therapy (Jayakumar et al. 2010 , Muzzarelli 2009 ) and as enzyme support 44 (Sjoholm et al. 2009 ). Chitosan also exhibits antimicrobial, antifungal or anti-45 hypercholesterolemic activities (Aranaz et al. 2014 , Xia et al. 2011 , which are 46 dependent on its molecular weight (MW) and deacetylation degree (DD). However, 47
some applications of chitosan are limited by its high viscosity and low aqueous 48 solubility at neutral pH. 49
Chitooligosaccharides (COS) are obtained by partial hydrolysis of chitosan and are 50 formed by random GlcNAc and D-glucosamine (GlcN) units. COS present a degree of 51 polymerization (DP) lower than 20 (MW ≤ 4000), are soluble in water and display 52 antimicrobial, antioxidant, antiviral, antiangiogenic, antitumoral and prebiotic properties 53 (Sanchez et al. 2017 , Zou et al. 2016 industry. Interestingly, some commercial enzyme preparations are able to hydrolyze 83 chitosan (Pantaleone et al. 1992 ). Such activity is usually low, probably because 84 chitosanolytic activity represents a minor contribution to total enzyme activity in such 85 extracts (Fu et al. 2003) .
86
In this work we describe the screening of chitosanolytic activity in a series of 87 commercial enzymes, followed by the identification and quantification (by the 88 combined use of chromatographic and mass spectrometry techniques) of the COS 89 synthesized by a neutral protease preparation. The neuroprotective and anti-90 inflammatory activities of the synthesized COS were further assessed. 91 
MATERIALS AND METHODS
Activity assay 108
Chitosanolytic activity was determined by detection of reducing sugars with a 109 modified 3,5-dinitrosalicylic acid (DNS) method (Ghazi et al. 2007 ). Prior to the assay, 110
low-molecular-weight contaminants in the enzyme samples were removed with a PD-10 111 desalting column (GE Healthcare, Uppsala, Sweden). Reactions were performed in 1.5 112 mL centrifuge tubes by addition of 200 µL of enzyme to 800 µL of 1% (w/v) chitosan 113 CHIT100 dissolved in 50 mM sodium acetate buffer (pH 5.0). Tubes were incubated at 114 50°C and 1,400 rpm in a Thermo Shaker TS-100 (Boeco, Hamburg, Germany) and 115 reactions were stopped by addition of 0.25 M NaOH in a 1/1 (v/v) ratio. The addition of 116
NaOH also caused the precipitation of the remaining polysaccharide, which was 117 removed by centrifugation at 5,000x g for 10 min. The quantification of reducing sugars 118
in the supernatant was carried out by the DNS method in a 96-well microplate with a 119 calibration curve of D-glucosamine. One unit of activity (U) corresponded to the release 120 of one µmol of reducing sugars per minute. 121
SDS-PAGE and zymogram 122
Proteins were visualized by electrophoresis in denaturing conditions in 12% 123 acrylamide gels. Samples were prepared as follows: 15 µL of commercial preparation 124
conveniently diluted was mixed with 5 µL of 4x loading buffer with β-mercaptoethanol 125
and heated for 10 min at 96°C. Gel was stained with ProtoStain Blue (National 126
Diagnosis, USA) and bands were compared with molecular weight markers (Precision 127
Plus Protein™ All Blue Pre-stained Protein Standards, BioRad, USA).
128
Chitosanolytic activity in gel was assayed by native polyacrylamide gel 129 electrophoresis in 12% gels without SDS containing 0.1% (w/v) glycol chitosan 130
following the Laemmli method (Laemmli 1970) . After electrophoresis the gel was 131 soaked in 100 mM sodium acetate buffer (pH 5.0) with 1% (v/v) Triton X-100 and 132 incubated for 2 h at 37°C. The gel was washed with distilled water and stained with 133
Congo red (0.1%). The contrast was enhanced for the development of dark blue colour 134
with the addition of 5% (v/v) acetic acid. Chitosanolytic activity was observed as a clear 135 area against a dark blue background. 136
Analysis of chitosan hydrolysis by SEC-ELSD 137
To 960 µL of a 1% (w/v) chitosan solution in 50 mM sodium acetate buffer (pH 138 5.0), Neutrase (40 µL) was added. Reactions were incubated at 50°C in 1.5 mL 139 centrifuge tubes at 900 rpm with orbital shaking. At different times, aliquots were taken, 140 diluted with water, and filtered with 0.45 µm cellulose filters (Analisis Vinicos, 141
Tomelloso, Spain). Samples were analyzed by size exclusion chromatography (SEC) 142
using a ternary pump (Varian) and a PolySep-4000 column (7.8 x 300 mm, 143
Phenomenex, Torrance, CA) coupled to an evaporative light scattering detector (ELSD 144
2000ES, Alltech). Mobile phase was 0.25 M ammonium acetate (pH 4.7) at 0.6 145 mL/min. ELSD conditions were set at 115°C and a nitrogen flow of 3.5 L/min. 146
Characterization and quantification of COS by HPAEC-PAD 147
Reactions were performed as described in Section 2.4. In this case, aliquots were 148 mixed with 0.25 M NaOH in a 1/1 (v/v) ratio to stop the reaction and to precipitate the 149 remaining polysaccharide, which was removed by centrifugation at 5,000x g for 10 min. 150
The supernatant was diluted with water (2.5 mM NaOH final concentration) and 151
analyzed by HPAEC-PAD on a The anti-inflammatory activity was assayed on macrophages that were cultured and 200 plated as described for the viability assay. After 10 min incubation of the cells with the 201 tested COS (at the three assayed concentrations), 100 ng/mL of lipopolysaccharide 202
(LPS) was added. Cell viability was evaluated 24 hours after compound addition by 203 mitochondrial MTT assay. In order to obtain a product enriched in deacetylated COS, and given that several activity in Neutrase 0.8L had not been described before. This enzymatic preparation 229
was also assayed towards other chitosans with different MW and DD (Table 2) . 230
Interestingly, the activity was similar with all the substrates, despite the substantially 231 differences in their deacetylation degree. 232
The protein profile of Neutrase 0.8L was analyzed by SDS-PAGE in denaturing 233 conditions, and compared with an activity gel in native conditions. Figure 1 shows the 234 presence of several proteins with MW < 75 kDa. The neutral protease of B. 235
amyloliquefaciens is reported in the UniProt database (accession number: Q44677) to 236 have a molecular mass of 56.7 kDa. This correlated well with the most intense band in 237
the SDS-PAGE. The activity gel (Fig. 1) was not directly comparable with the SDS-238 PAGE gel because the behavior of proteins under native conditions is different than 239 under denaturing conditions. However, observing the lytic band corresponding to the 240 Neutrase 0.8L preparation (Fig 1, lane 2, white arrow) , we concluded that the 241 chitosanolytic activity did not correlate with the main band of the SDS-PAGE (the 242 neutral protease). 243
Monitoring of chitosan hydrolysis by SEC-HPLC 244
The hydrolysis of chitosan catalyzed by Neutrase 0.8L was followed by size 245 exclusion chromatography with evaporative light-scattering detection (SEC-ELSD). 246 Figure 2 shows the progress of the reaction with chitosan CHIT600 as substrate. The 247
high-molecular-weight (HMW) chitosan (peak 1) disappeared after 24 h, which 248 indicated efficient hydrolysis of the substrate. A new peak appeared (2) with the same 249 retention time that a chitosan oligosaccharide standard (MW ≤ 2000). The monomers 250
(GlcN and GlcNAc) and the buffer salts coeluted in peak 3. However, the specific 251 composition of the COS fraction cannot be inferred by this methodology. The reactions 252
using chitosans of different DP and DD gave rise to similar SEC-HPLC profiles (data 253 not shown). In conclusion, SEC-ELSD analyses confirmed the complete disappearance 254 of the HMW chitosan after 24 h under the assayed conditions. 255
Identification of COS by mass spectrometry 256
Mass be the protease itself. On the contrary, in our case, we observed that the neutral protease 272
was not responsible of the chitosanolytic activity, whilst it could catalyze the 273 deacetylating process.
274
In a recent work, we developed a dual reactor for COS production using the 275 chitosanolytic activity present in another enzymatic preparation (BAN) which could be related with the absence of protease activity in such preparation. 279
Quantification of COS by HPAEC-PAD 280
Since COS properties are highly dependent on their charge (related to their DD) and 
289
COS are poorly retained at alkaline pH on anion-exchange columns typically employed 290
to separate carbohydrates, thus requiring unusual mobile phase conditions. 291
HPAEC-PAD was employed to identify ( Fig. 4) and quantify (Fig. 5 ) the COS 292
obtained by the hydrolysis of the four chitosans (CHIT100, CHIT600, QS1 and QS2) 293
with Neutrase 0.8L. The four reactions were carried out under the same conditions and 294 treated in the same way for their comparison. In order to avoid damage of the HPAEC-295
PAD column, any residual chitosan in the reaction mixtures (HMW chitosan, peak 1 in 296
Figure 2) was removed by precipitation with 0.25 M NaOH (1:1 v/v) followed by 297
centrifugation. The addition of alkali also allowed to inactivate the enzyme and to 298 increase the sensitivity of the detector. 299
In a previous work, we demonstrated that a Carbo-Pack PA-200 column was 300 appropriate for the separation of complex mixtures of COS in less than 30 min 301 employing a diluted NaOH solution (4 mM) as mobile phase (Santos-Moriano et al. With the aid of commercial standards, GlcN (peak 1), (GlcN) 2 (2), (GlcN) 3 (3), 309
(GlcN) 4 (4) and (GlcN) 5 (5) were identified by HPAEC-PAD ( Fig. 4 ) and further 310 quantified (Fig. 5 ). The order of elution with PA-200 columns usually correlates with 311 the increasing degree of polymerization (DP), because more sugar moieties imply a 312
higher negative charge to interact with the positive stationary phase. However, it is 313 noteworthy that the retention time in the glucosamine series did not follow such order 314 e.g. (GlcN) 3 eluted between GlcN and (GlcN) 2 , probably due to the unusual eluting 315 conditions (4 mM NaOH) and that the most acidic hydroxyl groups of glucose moieties 316
(2-OH) are substituted by NH 2 . 317
An additional problem is that alkaline mobile phases typically employed in HPAEC-318 PAD methods may cause epimerization of the N-acetyl-D-glucosamine moiety to N-319 acetyl-D-mannosamine (ManNAc) (Lee 1996) , thus artificially increasing the number 320 of analytes in the sample. We observed that the low concentration of NaOH (4 mM) 321
used in our method did not promote epimerization of COS at least during the time of 322 analysis (30 min).
323
In accordance with the SEC-HPLC study, chitosans CHIT100 and CHIT600 (initial 324 concentration 10 g/L) were fully converted into COS in 24 h, yielding approximately 325 2.5 g/L of (GlcN) 2 , 4.5 g/L of (GlcN) 3 and 3 g/L of (GlcN) 4 . The HPAEC-PAD results 326 also correlated well with data from MS analysis. 327
Biological activity of COS 328
The reaction of Neutrase with chitosan CHIT600 was scaled-up (50 mL) for the 329 production of fully deacetylated COS to assess their biological properties. A mixture of 330 25% (GlcN) 2, 45% (GlcN) 3 and 30% (GlcN) 4 was obtained. The yield of the purification 331 was 80%, and the protein content was almost negligible. 332
It has been postulated that deacetylation exerts a notable influence on the bioactivity 333 of these molecules. Thus, the increased hypocholesterolemic activity of deacetylated 334 derivatives could be attributed to the electrostatic attraction between charged amino 335 groups and anionic bile salts and fatty acids (Xia et al. 2011) . In contrast, partially 336 acetylated COS exhibit better antibacterial activity towards Escherichia coli and 337
Listeria monocytogenes than those fully deacetylated (Sanchez et al. 2017 ). In the 338 present work, we studied the neuroprotective and anti-inflammatory activities of the In the present work, the neuroprotective activity of deacetylated COS produced 356
by Neutrase 0.8L towards human SH-S5Y5 neurons was tested. First, viability of cells 357
in the presence of COS at three concentrations (0.02, 0.2 and 2 mg/mL) was assayed.
358
COS were not toxic for the cells (Fig. 6A) . These concentrations were then tested for 359 the neuroprotective activity in the presence of H 2 O 2 (Fig. 6B ). Values above 100% 360 indicated neuroprotection. COS showed a dose-dependent behavior increasing cells 361 viability after exposure to hydrogen peroxide (Fig. 6B) . In particular, the activity was 362 higher at the lowest assayed concentration (0.02 mg/mL), at which the neuroprotective 363 effect was statistically significant. The effect was slightly better than the observed with 364 fructooligosaccharide standards. 365
Anti-inflammatory activity 366
Chitosan oligosaccharides have been reported to exert an anti-inflammatory 367 effect via the stimulus of tumor necrosis factor-α (TNF-α) in the LPS-induced 368 inflammation in RAW cells (Yoon et al. 2007 were not toxic for the cells, and even increased significantly the viability of the cells at 377 low concentrations (Fig. 7A) . The same concentrations were tested for the anti-378 inflammatory activity measuring cell viability after inflammation caused by 100 ng/mL 379 LPS. COS showed certain anti-inflammatory activity at the three concentrations 380 assayed, although none of them was statistically significant (Fig. 7B ). However, unlike 381 the case of the neuroprotective activity, the effect was not greater than the obtained with 382
other functional sugars such as fructooligosaccharides. 383
CONCLUSIONS 384
We found a commercial enzyme preparation approved for food applications 385
(Neutrase 0.8L) that produced almost exclusively deacetylated COS from different 386 chitosans. The reaction was very efficient and the DP of the synthesized COS varied 387 from 2 to 4 (MW < 700). The process was scaled-up to produce a higher amount of 388 fully deacetylated COS and assess their neuroprotective and anti-inflammatory 389
activities. The COS mixture showed no toxicity on neurons and RAW cells, as well as a 390 moderate biological activity, similar to that obtained with other functional food 391
ingredients such as fructooligosaccharides. 392
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SUPPORTING INFORMATION 407
Mass spectra of Neutrase 0.8L reactions with different chitosans (CHIT100, QS1 and 408 QS2). (v/v) enzyme, 50°C, 50 mM sodium acetate buffer pH 5.0, 24 h. HMW chitosans were 570 precipitated prior to the analysis. Identified peaks: (1) GlcN;
(2) (GlcN) 2 ; (3) (GlcN) 3 ; 571
(4) (GlcN) 4 ; (5) (GlcN) 5 . 572 
